International Web-based consultation on priorities for translational breast cancer research
2007

International Web-based Consultation on Breast Cancer Research Priorities

Sample size: 420 publication Evidence: moderate

Author Information

Author(s): Mitch Dowsett, Aron Goldhirsch, Daniel F. Hayes, Hans-Joerg Senn, William Wood, Giuseppe Viale

Primary Institution: Royal Marsden Hospital

Hypothesis

What are the highest priority topics in translational breast cancer research as identified by professionals in the field?

Conclusion

The consultation identified key research priorities that may help focus resources on the most pressing issues in breast cancer research.

Supporting Evidence

  • 420 professionals participated in the voting process.
  • The top priority was to identify molecular signatures to select patients who could be spared chemotherapy.
  • Votes were recorded from participants across 48 countries.

Takeaway

Doctors and researchers voted on what they think is most important to study in breast cancer, and they found that figuring out which patients can skip chemotherapy is the top priority.

Methodology

An international Web-based consultation was conducted where breast cancer professionals voted on the most important research topics.

Potential Biases

The consultation may not fully represent the views of all professionals in the field due to varying participation rates.

Limitations

The voting may have been influenced by current trends and the opinions of a limited number of professionals.

Participant Demographics

Participants included clinicians, academics, research scientists, and pathologists from 48 countries, with 48% from North America.

Digital Object Identifier (DOI)

10.1186/bcr1798

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication